The Effects of Polypharmacy in Older Adults

被引：228
|
作者：
Hilmer, S. N. [1 ,2 ,3 ]
Gnjidic, D. [1 ,2 ,3 ]
机构：
[1] Royal N Shore Hosp, Dept Clin Pharmacol, St Leonards, NSW 2065, Australia
[2] Royal N Shore Hosp, Dept Aged Care & Rehabil, St Leonards, NSW 2065, Australia
[3] Univ Sydney, Fac Med, No Clin Sch, Sydney, NSW 2006, Australia
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2009年 / 85卷 / 01期
关键词：
LOWER-EXTREMITY FUNCTION; DRUG-DRUG INTERACTIONS; PHYSICAL PERFORMANCE; FUNCTIONAL OUTCOMES; ELDERLY POPULATION; NURSING-HOME; PEOPLE; FALLS; RISK; AGE;
D O I：
10.1038/clpt.2008.224
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
An assessment of the safety and efficacy of multiple medications in older adults requires clinically relevant objective outcomes and pharmacological measures of medication exposure. Important outcomes include geriatric syndromes and objective measures of physical function. Measurements of medication exposure have evolved from merely counting the drugs to a consideration of pharmacologic principles such as drug class, dose response, and maximal effect. Emerging evidence regarding the effects of cumulative medication exposure on functions critical for independence may provide guidance for prescribers.
引用
收藏
页码：86 / 88
页数：3
相关论文
共 50 条
  • [41] Polypharmacy and Cardiovascular Diseases: Consideration for Older Adults and Women
    Shreya Patel
    Manish Kumar
    Craig J. Beavers
    Saad Karamat
    Fawaz Alenezi
    Current Atherosclerosis Reports, 2022, 24 : 813 - 820
  • [42] Prevalence of polypharmacy in frail community dwelling older adults
    Ling, N.
    Chen, M.
    Ho, V.
    Lim, M.
    Merchant, R. A.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 : S219 - S219
  • [43] POLYPHARMACY NEGATIVELY AFFECTS ORAL HEALTH IN OLDER ADULTS
    不详
    AMERICAN JOURNAL OF NURSING, 2021, 121 (03) : 66 - 66
  • [44] Physical Condition and Risk of Hospitalization and Polypharmacy in Older Adults
    Fernandez-Araque, Ana
    Garcia-de-Diego, Laura
    Martinez-Ferran, Maria
    Diez-Vega, Ignacio
    Yvert, Thomas
    Mingo-Gomez, Maria Teresa
    Santiago, Catalina
    Pareja-Galeano, Helios
    Verde, Zoraida
    REJUVENATION RESEARCH, 2022, 25 (04) : 200 - 206
  • [45] Unseen and unheard: polypharmacy, older adults and sensory impairment
    Fuzesi, P.
    Broadfoot, K.
    Lennon, M.
    Welsh, T.
    Jacob, S. A.
    Macaden, L.
    Smith, A.
    Watson, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1484 - 1484
  • [46] ACUTE CONFUSIONAL STATES IN OLDER ADULTS AND THE ROLE OF POLYPHARMACY
    STEWART, RB
    HALE, WE
    ANNUAL REVIEW OF PUBLIC HEALTH, 1992, 13 : 415 - 430
  • [47] Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review
    Nicholson, Kathryn
    Liu, Winnie
    Fitzpatrick, Daire
    Hardacre, Kate Anne
    Roberts, Sarah
    Salerno, Jennifer
    Stranges, Saverio
    Fortin, Martin
    Mangin, Dee
    LANCET HEALTHY LONGEVITY, 2024, 5 (04): : e287 - e296
  • [48] Polypharmacy and Cardiovascular Diseases: Consideration for Older Adults and Women
    Patel, Shreya
    Kumar, Manish
    Beavers, Craig J.
    Karamat, Saad
    Alenezi, Fawaz
    CURRENT ATHEROSCLEROSIS REPORTS, 2022, 24 (10) : 813 - 820
  • [49] Polypharmacy in multimorbid older adults: protocol for a systematic review
    Sirois, Caroline
    Laroche, Marie-Laure
    Guenette, Line
    Kroger, Edeltraut
    Cooper, Dan
    Emond, Valerie
    SYSTEMATIC REVIEWS, 2017, 6
  • [50] Polypharmacy and the risk of fracture in older adults: A systematic review
    Gagnon, Marie Eve
    Talbot, Denis
    Tremblay, Florence
    Tourville, Marc Antoine
    Sirois, Caroline
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 388 - 388
12345